Synthesis of 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate and kinetic studies of Mycobacterium tuberculosis IspF
- PMID: 20189102
- PMCID: PMC2837070
- DOI: 10.1016/j.chembiol.2010.01.013
Synthesis of 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate and kinetic studies of Mycobacterium tuberculosis IspF
Abstract
Many pathogenic bacteria utilize the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway for the biosynthesis of isopentenyl diphosphate and dimethylallyl diphosphate, two major building blocks of isoprenoid compounds. The fifth enzyme in the MEP pathway, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (ME-CPP) synthase (IspF), catalyzes the conversion of 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (CDP-ME2P) to ME-CPP with a corresponding release of cytidine 5-monophosphate (CMP). Because there is no ortholog of IspF in human cells, IspF is of interest as a potential drug target. However, study of IspF has been hindered by a lack of enantiopure CDP-ME2P. Herein, we report the first, to our knowledge, synthesis of enantiomerically pure CDP-ME2P from commercially available D-arabinose. Cloned, expressed, and purified M. tuberculosis IspF was able to utilize the synthetic CDP-ME2P as a substrate, a result confirmed by mass spectrometry. A convenient, sensitive, in vitro IspF assay was developed by coupling the CMP released during production of ME-CPP to mononucleotide kinase, which can be used for high throughput screening.
Copyright 2010 Elsevier Ltd. All rights reserved.
Figures




Similar articles
-
Crystal structure of IspF from Bacillus subtilis and absence of protein complex assembly amongst IspD/IspE/IspF enzymes in the MEP pathway.Biosci Rep. 2018 Feb 21;38(1):BSR20171370. doi: 10.1042/BSR20171370. Print 2018 Feb 28. Biosci Rep. 2018. PMID: 29335298 Free PMC article.
-
Expression and characterization of soluble 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase from bacterial pathogens.Chem Biol. 2009 Dec 24;16(12):1230-9. doi: 10.1016/j.chembiol.2009.10.014. Chem Biol. 2009. PMID: 20064433 Free PMC article.
-
2C-Methyl-d-erythritol 4-phosphate enhances and sustains cyclodiphosphate synthase IspF activity.ACS Chem Biol. 2012 Oct 19;7(10):1702-10. doi: 10.1021/cb300243w. Epub 2012 Aug 6. ACS Chem Biol. 2012. PMID: 22839733 Free PMC article.
-
Isoprenoid biosynthesis via 1-deoxy-D-xylulose 5-phosphate/2-C-methyl-D-erythritol 4-phosphate (DOXP/MEP) pathway.Acta Biochim Pol. 2001;48(3):663-72. Acta Biochim Pol. 2001. PMID: 11833775 Review.
-
The Methylerythritol Phosphate Pathway: Promising Drug Targets in the Fight against Tuberculosis.ACS Infect Dis. 2018 Mar 9;4(3):278-290. doi: 10.1021/acsinfecdis.7b00176. Epub 2018 Feb 8. ACS Infect Dis. 2018. PMID: 29390176 Free PMC article. Review.
Cited by
-
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.FASEB J. 2014 Dec;28(12):5071-82. doi: 10.1096/fj.14-255786. Epub 2014 Aug 13. FASEB J. 2014. PMID: 25122556 Free PMC article.
-
Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.Sci Rep. 2015 Mar 6;5:8824. doi: 10.1038/srep08824. Sci Rep. 2015. PMID: 25744727 Free PMC article.
-
Formal Synthesis of 4-diphosphocytidyl-2-C-methyl D-erythritol From D-(+)-Arabitol.Tetrahedron. 2012 Oct 28;68(43):8937-8941. doi: 10.1016/j.tet.2012.08.020. Tetrahedron. 2012. PMID: 23049145 Free PMC article.
-
Current Development of Nano-Drug Delivery to Target Macrophages.Biomedicines. 2022 May 23;10(5):1203. doi: 10.3390/biomedicines10051203. Biomedicines. 2022. PMID: 35625939 Free PMC article. Review.
-
Synthetic Routes to Methylerythritol Phosphate Pathway Intermediates and Downstream Isoprenoids.Curr Org Chem. 2014 Apr;18(8):1050-1072. doi: 10.2174/1385272819666140501001101. Curr Org Chem. 2014. PMID: 25009443 Free PMC article.
References
-
- Bailey AM, Mahapatra S, Brennan PJ, Crick DC. Identification, cloning, purification, and enzymatic characterization of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate synthase. Glycobiology. 2002;12:813–820. - PubMed
-
- Brennan PJ, Crick DC. The cell-wall core of Mycobacterium tuberculosis in the context of drug discovery. Current Topics in Medicinal Chemistry. 2007;7:475–488. - PubMed
-
- Buhaescu I, Izzedine H. Mevalonate pathway: A review of clinical and therapeutical implications. Clinical Biochemistry. 2007;40:575–584. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases